An investigation of physicochemical properties of piroxicam liquisolid compacts

Pharmaceutical Development and Technology

Volumn 12, Issue 3, 2007, Pages 337-343

  Javadzadeh, Yousef ^a,b   Siahi, Mohammad Reza ^a   Asnaashari, Solmaz ^b   Nokhodchi, Ali ^a,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Aging; Differential scanning calorimetry; Dissolution rate; Liquisolid compacts; Piroxicam

Indexed keywords

DRUG CARRIER; EXCIPIENT; LACTOSE; MICROCRYSTALLINE CELLULOSE; PIROXICAM; POLYSORBATE 80; SILICON DIOXIDE; SOLVENT; SORBITOL; STARCH; STARCH GLYCOLATE SODIUM;

ARTICLE; CONTACT ANGLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; HUMIDITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TABLET; TABLET COMPRESSION; WETTABILITY; X RAY CRYSTALLOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMPOUNDING; PIROXICAM; TABLETS; X-RAY DIFFRACTION;

EID: 34347402980     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701247574     Document Type: Article

References (15)

1. Löbenberg, R.; Amidon, G.L. Modern bioavailability, bioequivalence and biopharmaceutics classification system; new scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000, 50, 3-12.
2. Kapsi, S.G.; Ayres, J.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 2001, 229, 193-203.
3. Aguiar, A.J.; Zelmer, A.J.; Kinkel, A.W. Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt. J. Pharm. Sci. 1967, 56, 1243-1252.
4. Finholt, P.; Solvang, S. Dissolution kinetics of drugs in human gastric juices the role of surface tension. J. Pharm. Sci. 1968, 57, 1322-1326.
5. Lin, S.L.; Menig, J.; Lachman, L. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J. Pharm. Sci. 1968, 57, 2143-2146.
6. Spireas, S.; Sadu, S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharma. 1998, 166, 177-188.
7. Spireas, S.; Sadu, S.; Grover, R. In vitro release evaluation of hydrocortisone liquisolid tablets. J. Pharm. Sci. 1998, 87, 867-872.
8. Spireas, S.; Wang, T.; Grover, R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev. Ind. Pharm. 1999, 25, 163-168.
9. Alsaidan, S.M.; Alsughayer, A.A.; Eshra, A.G. Improved dissolution rate of indomethacin by adsorbents. Drug Dev. Ind. Pharm. 1998, 24, 389-394.
10. Javadzadeh, Y.; Siahi, M.R.; Barzegar-Jalali, M.; Nokhodchi, A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il Farmaco, 2005, 60, 361-365.
11. Costa, P. An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm. 2001, 220, 77-83.
12. Wade, A.; Weller, P.J. Handbook of Pharmaceutical Excipients, 2nd ed.: The Pharmaceutical Press: London, 1994, 259, 477, 485.
13. Vrecer, F.; Vrbinc, M.; Meden, A. Characterization of piroxicam crystal modifications. Int. J. Pharm. 2003, 256, 3-15.
14. Abdou, H.M. Effect of the physicochemical properties of the drug on dissolution. In Dissolution, Bioavailability and Bioequivalence; Mack Pub. Co.: Easton, PA. 1989, 53-72.
15. Noyes, A.A.; Whitney, W.R. The rate of solution of solid substances in their own solutions, J. Am. Chem. Soc. 1897, 19, 930-934.